Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The two screenshots show no substantive changes to the study details, eligibility criteria, endpoints, or locations; any differences appear to be minor formatting or wording adjustments that do not affect the page's purpose. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-27T21:04:37.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Core content updated with an operating-status notice and a new version (v3.2.0); a specific resource (Small cell lung carcinoma) was removed (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T08:30:37.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page update adds the new version tag v3.1.0 and removes the old v3.0.2 tag, signaling a software version upgrade.
    Difference
    0.0%
    Check dated 2025-09-29T05:19:18.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed (a minor UI change).
    Difference
    0.1%
    Check dated 2025-09-14T22:47:42.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T19:43:46.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of detailed drug information for various medications and the inclusion of numerous specific locations across multiple countries. Notably, the facility name and location have been added, enhancing the core content of the page.
    Difference
    12%
    Check dated 2025-08-31T12:44:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.